TE_12393

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family L1HS_5end
TE superfamily L1
TE class LINE
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 173.85
Counts of samples TCGA_tumor:616; TCGA_normal:1; GTEx:2
TSS chr5(+):30823612



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_12393.31 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30828183,30828203
teRNA_12393.32 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30896207,30896279,30947401,30947421
teRNA_12393.33 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30844957,30845075,30896207,30896279,30928307,30928327
teRNA_12393.34 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30896207,30896279,30943485,30943564,30947401,30947421
teRNA_12393.35 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30896207,30896279,30942057,30942077
teRNA_12393.36 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30844957,30845075,30896207,30896279,30943485,30943564,30947401,30947421
teRNA_12393.37 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30844957,30845075,30896207,30896279,30942057,30943564,30947401,30947421
teRNA_12393.38 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30896207,30896279,30913555,30913575
teRNA_12393.39 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30896207,30896279,30947602,30947622
teRNA_12393.40 - Intergenic Non-coding Non-coding chr5(+):30823613,30824088,30824408,30824569,30825749,30825836,30844957,30845075,30850726,30850746


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).